Evaluation of Inhaled Colistin/Fosfomycin as an Adjunctive Treatment for Ventilator‐Associated Pneumonia: A Preliminary Study
Atousa Hakamifard, Mohammad Reza Mohammadi, Alireza Homayouni, Farzin Khorvash, Saeed Abbasi, Behrooz Ataei, Mahnaz Momenzadeh · 2025
Read Evaluation of Inhaled Colistin/Fosfomycin as an Adjunctive Treatment for Ventilator‐Associated Pneumonia: A Preliminary Study by Atousa Hakamifard, Mohammad Reza Mohammadi, Alireza Homayouni, Farzin Khorvash, Saeed Abbasi, Behrooz Ataei, Mahnaz Momenzadeh (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12715318.txt.
Description
Atousa Hakamifard and co-authors trial inhaled antibiotics as an add-on for ventilator pneumonia in a study from 2025. This lung illness, when caused by resistant germs, kills many patients in intensive care. One culprit, a hard-to-kill Acinetobacter, leaves few working options. Breathing the drugs straight into the lungs could raise local power.
The triple-blind trial split patients into two groups. All patients got meropenem plus colistin by vein as the base. The test group added inhaled colistin and fosfomycin on top. That drug has drawn fresh interest against hard-to-kill germs. Early data from such a small trial stays a first look by design. Drugs breathed into the lungs are a logical step when veins alone cannot reach the illness.
Catalog record
| CREATOR | Atousa Hakamifard, Mohammad Reza Mohammadi, Alireza Homayouni, Farzin Khorvash, Saeed Abbasi, Behrooz Ataei, Mahnaz Momenzadeh |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |